Ubs Asset Management Americas Inc Gilead Sciences, Inc. Transaction History

Ubs Asset Management Americas Inc

  • $446 Billion
  • Q3 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 12,988,515 shares of GILD stock, worth $1.61 Billion. This represents 0.32% of its overall portfolio holdings.

Number of Shares
12,988,515
Previous 16,583,078 21.68%
Holding current value
$1.61 Billion
Previous $1.84 Billion 21.58%
% of portfolio
0.32%
Previous 0.39%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$108.22 - $120.47 $389 Million - $433 Million
-3,594,563 Reduced 21.68%
12,988,515 $1.44 Billion
Q2 2025

Aug 14, 2025
BUY
$96.91 - $113.0 $274 Million - $320 Million
2,827,597 Added 20.56%
16,583,078 $1.84 Billion
Q1 2025

May 19, 2025
BUY
$89.14 - $117.41 $136 Million - $179 Million
1,520,809 Added 12.43%
13,755,481 $1.54 Billion
Q4 2024

Feb 14, 2025
BUY
$83.95 - $97.9 $135 Million - $157 Million
1,605,730 Added 15.11%
12,234,672 $1.13 Billion
Q3 2024

Nov 14, 2024
SELL
$66.59 - $83.99 $34 Million - $42.9 Million
-510,833 Reduced 4.59%
10,628,942 $891 Million
Q2 2024

Aug 13, 2024
BUY
$63.15 - $72.88 $102 Million - $118 Million
1,614,934 Added 16.95%
11,139,775 $764 Million
Q1 2024

May 15, 2024
BUY
$71.58 - $87.29 $5.64 Million - $6.88 Million
78,816 Added 0.83%
9,524,841 $698 Million
Q4 2023

Feb 14, 2024
BUY
$73.27 - $83.09 $6.61 Million - $7.49 Million
90,164 Added 0.96%
9,446,025 $765 Million
Q3 2023

Nov 13, 2023
BUY
$73.94 - $80.67 $33.3 Million - $36.4 Million
450,908 Added 5.06%
9,355,861 $701 Million
Q1 2023

May 15, 2023
SELL
$77.31 - $88.08 $36.2 Million - $41.3 Million
-468,432 Reduced 5.0%
8,904,953 $739 Million
Q4 2022

Feb 14, 2023
SELL
$62.32 - $89.47 $30.4 Million - $43.7 Million
-488,144 Reduced 4.95%
9,373,385 $805 Million
Q3 2022

Nov 14, 2022
BUY
$59.54 - $68.01 $38.5 Million - $43.9 Million
646,166 Added 7.01%
9,861,529 $608 Million
Q2 2022

Aug 12, 2022
SELL
$57.72 - $65.01 $149 Million - $167 Million
-2,573,580 Reduced 21.83%
9,215,363 $570 Million
Q1 2022

May 16, 2022
BUY
$57.92 - $72.58 $146 Million - $183 Million
2,527,753 Added 27.29%
11,788,943 $701 Million
Q4 2021

Feb 14, 2022
BUY
$64.88 - $73.64 $21.7 Million - $24.6 Million
334,255 Added 3.74%
9,261,190 $672 Million
Q3 2021

Nov 15, 2021
BUY
$67.69 - $73.03 $16.5 Million - $17.8 Million
244,381 Added 2.81%
8,926,935 $624 Million
Q2 2021

Aug 16, 2021
SELL
$63.47 - $69.35 $24 Million - $26.2 Million
-377,950 Reduced 4.17%
8,682,554 $598 Million
Q1 2021

May 14, 2021
BUY
$60.0 - $68.46 $3.81 Million - $4.34 Million
63,451 Added 0.71%
9,060,504 $586 Million
Q4 2020

Mar 01, 2021
BUY
$56.65 - $64.55 $22.3 Million - $25.4 Million
392,859 Added 4.57%
8,997,053 $524 Million
Q3 2020

Nov 13, 2020
BUY
$62.1 - $78.08 $21.7 Million - $27.3 Million
349,009 Added 4.23%
8,604,194 $544 Million
Q2 2020

Aug 14, 2020
BUY
$72.34 - $84.0 $106 Million - $124 Million
1,471,150 Added 21.69%
8,255,185 $635 Million
Q1 2020

May 15, 2020
BUY
$62.63 - $80.22 $9.97 Million - $12.8 Million
159,122 Added 2.4%
6,784,035 $507 Million
Q4 2019

Feb 14, 2020
BUY
$61.62 - $67.78 $743,445 - $817,765
12,065 Added 0.18%
6,624,913 $430 Million
Q3 2019

Nov 14, 2019
BUY
$62.51 - $69.0 $8.11 Million - $8.96 Million
129,795 Added 2.0%
6,612,848 $419 Million
Q2 2019

Aug 15, 2019
SELL
$61.87 - $69.38 $29.6 Million - $33.2 Million
-478,760 Reduced 6.88%
6,483,053 $0
Q1 2019

May 14, 2019
BUY
$62.53 - $70.05 $53.2 Million - $59.6 Million
850,855 Added 13.92%
6,961,813 $0
Q4 2018

Feb 13, 2019
BUY
$60.54 - $79.0 $11.2 Million - $14.6 Million
185,259 Added 3.13%
6,110,958 $382 Million
Q3 2018

Nov 14, 2018
SELL
$71.28 - $78.92 $6.89 Million - $7.63 Million
-96,705 Reduced 1.61%
5,925,699 $0
Q2 2018

Aug 14, 2018
BUY
$64.88 - $75.68 $17.6 Million - $20.5 Million
271,398 Added 4.72%
6,022,404 $0
Q1 2018

May 14, 2018
SELL
$72.84 - $88.8 $14.6 Million - $17.8 Million
-199,923 Reduced 3.36%
5,751,006 $0
Q4 2017

Feb 09, 2018
SELL
$71.15 - $83.52 $26.8 Million - $31.5 Million
-376,866 Reduced 5.96%
5,950,929 $0
Q3 2017

Nov 13, 2017
BUY
$72.11 - $85.47 $456 Million - $541 Million
6,327,795
6,327,795 $0

Others Institutions Holding GILD

# of Institutions
2,369
Shares Held
1.01B
Call Options Held
8.58M
Put Options Held
7.35M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $156B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email